课题基金 / 基金详情

项目摘要

项目成果

Stuart James Shankland的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Kidney disease is increasing at epidemic rates in the US. One clinical sign of kidney disease is protein in the urine (proteinuria). This is typically due to a leak in the normal filtration barrier, and in part is due to injury to a cell called the podocyte. Podocytes are specialized cells that function to limit proteinuria. However, in many diseases including diabetes, podocytes are injured to the point of death, referred to as apoptosis. Moreover, as podocytes die, the remaining podocytes are unable to proliferate and replenish those lost, resulting in a decrease in podocyte number. This further reduces the barrier function of these cells and ultimately leads to kidney failure. The purpose of this grant is to define novel mechanisms underlying podocyte death. Our group has focused in molecules called cell cycle proteins, which reside in the nucleus of the cell. In this grant, we will test the hypothesis that newly discovered cell cycle proteins called cyclin I and cdk5 form a complex which functions to protect podocytes from death in disease. We also believe another partner called p21 adds to this protective function. We will explore possibilities using podocytes in a cell culture system, and also in mice that have been genetically altered to be born without cyclin I, cdk5 and p21. The overall goal is to delineate new paradigms in the regulation of podocyte survival and death, so that ultimately new strategies can be developed to prevent podocyte loss, enhance kidney survival, and reduce kidney disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Intersection of Podocyte Disease and Aging
  • 批准号:
    10733868
  • 项目类别:
  • 资助金额:
    $76.29万
  • 财政年份:
    2023
  • 负责人:
    Stuart James Shankland
  • 依托单位:
Targeting Podocyte-Endothelial Cell Crosstalk as a FSGS Therapy
  • 批准号:
    10635547
  • 项目类别:
  • 资助金额:
    $77.52万
  • 财政年份:
    2023
  • 负责人:
    Stuart James Shankland
  • 依托单位:
Autocrine and paracrine podocyte signals decrease glomerular function/health in aged kidneys
  • 批准号:
    10698100
  • 项目类别:
  • 资助金额:
    $73.57万
  • 财政年份:
    2022
  • 负责人:
    Stuart James Shankland
  • 依托单位:
Kidney Aging Impairs Progenitor and Endocrine Function
  • 批准号:
    10549835
  • 项目类别:
  • 资助金额:
    $60.87万
  • 财政年份:
    2020
  • 负责人:
    Stuart James Shankland
  • 依托单位:
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2016
  • 负责人:
    陈昊
  • 依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 项目类别:
    面上项目
  • 资助金额:
    73.0万元
  • 批准年份:
    2014
  • 负责人:
    董家鸿
  • 依托单位: